Publications

Showing 3 of 3 Publications

2023

TCT-67 Comparison of In-Hospital Outcomes and 30-Day Readmission Rates Between Patients Who Underwent TAVR Versus SAVR for Aortic Stenosis in Liver Cirrhosis: A Propensity-Matched Analysis
Aggarwal A, Jang S, Vardhan S, Webber F, Lancaster G, Zarich S, Vora A, Elmariah S, Davila C. TCT-67 Comparison of In-Hospital Outcomes and 30-Day Readmission Rates Between Patients Who Underwent TAVR Versus SAVR for Aortic Stenosis in Liver Cirrhosis: A Propensity-Matched Analysis. Journal Of The American College Of Cardiology 2023, 82: b27. DOI: 10.1016/j.jacc.2023.09.072.
Peer-Reviewed Original Research
Concepts
COMPARISON OF IN - HOSPITAL OUTCOMES AND THIRTY - DAY READMISSION RATES BETWEEN PATIENTS WHO UNDERWENT TAVR VERSUS SAVR FOR AORTIC STENOSIS IN LIVER CIRRHOSIS: RESULTS FROM NATIONWIDE READMISSIONS DATABASE
Aggarwal A, Jang S, Webber F, Shkolnik E, Pinto E, Lancaster G, Zarich S. COMPARISON OF IN - HOSPITAL OUTCOMES AND THIRTY - DAY READMISSION RATES BETWEEN PATIENTS WHO UNDERWENT TAVR VERSUS SAVR FOR AORTIC STENOSIS IN LIVER CIRRHOSIS: RESULTS FROM NATIONWIDE READMISSIONS DATABASE. Journal Of The American College Of Cardiology 2023, 81: 1020. DOI: 10.1016/s0735-1097(23)01464-x.
Peer-Reviewed Original Research
Concepts

2011

Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin
Baek S, Jang S, Park S, Ok T, Leem J, Lee H, Park S, Kim T. Fatal Rhabdomyolysis in a Patient with Liver Cirrhosis after Switching from Simvastatin to Fluvastatin. Journal Of Korean Medical Science 2011, 26: 1634-1637. PMID: 22148003, PMCID: PMC3230026, DOI: 10.3346/jkms.2011.26.12.1634.
Peer-Reviewed Original Research
MeSH Keywords and Concepts

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply